期刊
ONCOLOGY REPORTS
卷 38, 期 2, 页码 611-624出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/or.2017.5718
关键词
nanoparticles; drug carriers; cancer treatment; delivery system; clinical trials
类别
资金
- Scholarship Award for Excellent Doctoral Student Granted of Yunnan Province [6011418150]
- Foundation of Leading Talent Program of Health and Family Planning Commission of Yunnan Province [L-201205]
- Foundation of Institute of Gastroenterology, Research institutions attached to Health and Family Planning Commission of Yunnan Province [2014NS122]
Nanomaterials are increasingly used as drug carriers for cancer therapy. Nanomaterials also appeal to researchers in the areas of cancer diagnosis and biomarker discovery. Several antitumor nanodrugs are currently being tested in preclinical and clinical trials and show promise in therapeutic and other settings. We review the development of nanomaterial drug carriers, including liposomes, polymer nanoparticles, dendritic polymers, and nanomicelles, for the diagnosis and treatment of various cancers. The prospects of nanomaterials as drug carriers for future clinical applications are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据